Canine prostate induces new bone formation in mouse calvaria: A model of osteoinduction by prostate tissue

Prostate

Volumn 50, Issue 2, 2002, Pages 104-111

  LeRoy, Bruce E ^a   Bahnson, Robert R ^a   Rosol, Thomas J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Bone formation; Dog; Osteoblastic metastases; Prostate cancer; Prostate gland

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCEIN; COLLAGENASE; GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MATRIX; BONE METASTASIS; BONE MINERALIZATION; CALVARIA; CONTROLLED STUDY; DOG; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PARACRINE SIGNALING; PERIOSTEUM; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMALS; BONE DEVELOPMENT; BONE NEOPLASMS; CALCIFICATION, PHYSIOLOGIC; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; MALE; MICE; MICE, NUDE; OSTEOCLASTS; PROSTATE; PROSTATIC NEOPLASMS; SKULL; TISSUE TRANSPLANTATION;

EID: 0036468823     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10037     Document Type: Article

References (36)

1. Osteoblastic metastasis in advanced prostate cancer
2. Mechanisms of bone metastasis
3. Cancer and bone
4. Pathophysiologic interactions in skeletal metastasis
5. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer
6. TGF β in prostate cancer: A growth inhibitor that can enhance tumorigenicity
7. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies
8. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells
9. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia
10. The role of endothelin-1 and endothelin receptor antagonists in prostate cancer
11. A carboxyl-terminal peptide from the parathyroid hormone-related protein inhibits bone resorption by osteoclasts
12. Establishment of human prostate carcinoma skeletal metastasis models
13. New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade
14. A model for prostate cancer bone metastasis: Direct intra-bone injection of prostate cancer xenografts
15. Prostatic intraepithelial neoplasia in dogs with spontaneous prostate cancer
16. Stromal and epithelial cells of the canine prostate express parathyroid hormone-related protein, but not the PTH/PTHrP receptor
17. Production of endothelin by canine prostatic epithelial cells and its stimulatory effects on their growth
18. Effects of infusion of human parathyroid hormone-related protein-(1-40) in nude mice: Histomorphometric and biochemical investigations
19. Age-related and sex hormone-induced changes in the canine prostate
20. Skeletal metastasis of prostate adenocarcinoma in rats: Morphometric analysis and role of parathyroid hormone-related protein
21. Stimulation of bone formation in vitro and in rodents by statins
22. Prostate carcinoma: Production of bioactive factors
23. Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen
24. Effect of various parathyroid hormone-related proteins (PTHrP) fragments on bone resportion and formation in vivo
25. Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era
26. Parathyroid hormone-related protein is not an autocrine growth factor for normal prostatic epithelial cells
27. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells
28. Upregulation of endothelin 1 and its precursor by IL-1beta, TNF-alpha, and TGF-beta in the PC3 human prostate cancer cell line
29. Osteoblastic bone metastases: Tumor-produced endothelin-1 mediates new bone formation via the endothelin A receptor
30. Characteristics of nonneoplastic human prostate tissue transplanted into nude mice
31. A method of in vivo maintenance of human prostatic tissue in immunosuppressed mice
32. Elevated expression of FGF-2 does not cause prostate cancer progression in LNCaP cells
33. Cell biology of the osteoclast
34. Expression of cytokines enhancing the osteoclast activity, and parathyroid hormone-related protein in prostatic cancers before and after endocrine therapy: An immunohisto-chemical study
35. Breast cancer cells interact with osteoblasts to support osteoclast formation
36. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord